Egetis Therapeutics AB Statistics

Total Valuation

BST:P0F has a market cap or net worth of EUR 187.73 million. The enterprise value is 175.33 million.

Market Cap	187.73M
Enterprise Value	175.33M

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	395.16M
Shares Outstanding	n/a
Shares Change (YoY)	+18.43%
Shares Change (QoQ)	+8.45%
Owned by Insiders (%)	10.15%
Owned by Institutions (%)	17.99%
Float	231.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.40
PS Ratio	32.56
PB Ratio	6.00
P/TBV Ratio	6.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.54
EV / Sales	30.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.07

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.24.

Current Ratio	1.05
Quick Ratio	1.01
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-14.98

Financial Efficiency

Return on equity (ROE) is -82.37% and return on invested capital (ROIC) is -41.23%.

Return on Equity (ROE)	-82.37%
Return on Assets (ROA)	-29.69%
Return on Invested Capital (ROIC)	-41.23%
Return on Capital Employed (ROCE)	-85.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	137,284
Profits Per Employee	-753,523
Employee Count	42
Asset Turnover	0.09
Inventory Turnover	30.30

Taxes

In the past 12 months, BST:P0F has paid 36,961 in taxes.

Income Tax	36,961
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.43%
50-Day Moving Average	0.43
200-Day Moving Average	0.51
Relative Strength Index (RSI)	49.93
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BST:P0F had revenue of EUR 5.77 million and -31.65 million in losses. Loss per share was -0.09.

Revenue	5.77M
Gross Profit	1.15M
Operating Income	-31.42M
Pretax Income	-31.61M
Net Income	-31.65M
EBITDA	-28.51M
EBIT	-31.42M
Loss Per Share	-0.09

Balance Sheet

The company has 19.94 million in cash and 7.59 million in debt, with a net cash position of 12.35 million.

Cash & Cash Equivalents	19.94M
Total Debt	7.59M
Net Cash	12.35M
Net Cash Per Share	n/a
Equity (Book Value)	31.30M
Book Value Per Share	0.08
Working Capital	1.17M

Cash Flow

In the last 12 months, operating cash flow was -24.67 million and capital expenditures -138,604, giving a free cash flow of -24.81 million.

Operating Cash Flow	-24.67M
Capital Expenditures	-138,604
Free Cash Flow	-24.81M
FCF Per Share	n/a

Margins

Gross Margin	19.87%
Operating Margin	-544.87%
Pretax Margin	-548.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BST:P0F does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.43%
Shareholder Yield	-18.43%
Earnings Yield	-16.86%
FCF Yield	-13.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:P0F has an Altman Z-Score of -2.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.24
Piotroski F-Score	3